The U.S. Centers for Medicare & Medicaid Services has followed through on an earlier threat to reduce payments for various sorts of radiology services in the physician fee schedule, including those invoked during episodes of cancer care, but Congress may yet intervene.
Electrical stimulation of the spinal cord has restored the ability to walk normally to a patient whose chronic Parkinson’s disease (PD) had led to severe motor deficits, researchers reported in the Nov. 6, 2023, online issue of Nature Medicine.
Abbott Laboratories received U.S. FDA approval for its molecular human papillomavirus (HPV) screening test, expanding the company’s cancer screening tools. The new member of the Alinity M family of diagnostic assays can be used for screening, as recommended by current guidelines, as well as diagnosis and provide detailed information on the potentially cancer-causing genotypes of the virus.
Illumina Inc. launched the next generation of its distributed liquid biopsy assay for genomic profiling. The updated Trusight Oncology (TSO) ctDNA v2, currently available for research use only, allows comprehensive genomic profiling (CGP) of circulating tumor DNA with only a blood sample.
Bongenix LLC reported the issuing of its very first patent, in which a non-invasive bone stimulating method and device are described for treating injured or diseased bone tissue with electricity.
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Carthera, Histosonics, Inspira Technologies, Mannkind, Ora Medical, Orthopediatrics, Revive Therapeutics.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Smileyscope.
Med-tech saw some good news in October, with total financings value reaching $1.22 billion, an increase of 89.23% from the $645.75 million in September. However, the increase didn’t make up for the broader year-over-year decline in med-tech investments.
RSS
